Moolec Science (MLECW) Cash from Investing Activities (2023 - 2024)
Moolec Science (MLECW) posted Cash from Investing Activities of -$10.0 million for Q4 2024, down 16615.14% sequentially from -$59738.0 in Q3 2024, and up 1.39% YoY from -$9.8 million in Q1 2024.
Moolec Science (MLECW) Cash from Investing Activities (2023 - 2024) Analysis & Trends
Moolec Science has reported Cash from Investing Activities for 2 years, with the latest figure at -$10.0 million in Q4 2024.
- Quarterly Cash from Investing Activities rose 1.39% year-over-year to -$10.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$37.5 million (down 5.29% YoY) and the FY2025 annual result came in at -$36.0 million, down 31.34% from the prior year.
- Cash from Investing Activities eased to -$10.0 million in Q4 2024 per MLECW's latest filing, from -$59738.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $174563.0 in Q3 2023 and troughed at -$27.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.99 Mn |
| Dec 31, 2024 | -9.99 Mn |
| Sep 30, 2024 | -59,738.00 |
| Sep 30, 2024 | -59,738.00 |
| Jun 30, 2024 | -27.56 Mn |
| Jun 30, 2024 | -27.56 Mn |
| Mar 31, 2024 | 112,476.00 |
| Mar 31, 2024 | 112,476.00 |
| Dec 31, 2023 | -10.13 Mn |
| Dec 31, 2023 | -10.13 Mn |
| Sep 30, 2023 | 174,563.00 |
| Sep 30, 2023 | 174,563.00 |
| Jun 30, 2023 | -25.44 Mn |
| Jun 30, 2023 | -25.44 Mn |
| Mar 31, 2023 | -215,152.00 |
| Mar 31, 2023 | -215,152.00 |